Skip to main content

Table 1 Characteristics of the SQ®-HDM registered tablet [9]

From: New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets

Proteins from D. pteronissynus, percent50%
Proteins from D. farinae, percent50%
Proportion of group I/group II allergens1/1
Der p 1 + Der p 2 content15 µg
Der f 1 + Der f 2: content15 µg
Formulation (orodispersible)Zydis® technology
Time to full dissolution in oral cavity3–4 s